Perkins Capital Management Inc Castle Biosciences Inc Transaction History

Perkins Capital Management Inc

$102 Million
Q3 2024

A detailed history of Perkins Capital Management Inc transactions in Castle Biosciences Inc stock. As of the latest transaction made, Perkins Capital Management Inc holds 32,640 shares of CSTL stock, worth $898,579. This represents 0.91% of its overall portfolio holdings.

Number of Shares

32,640

Previous 31,090 4.99%

Holding current value

$898,579

Previous $676,000 37.57%

% of portfolio

0.91%

Previous 0.67%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$17.4 - $31.47 $26,969 - $48,778	1,550 Added 4.99%	32,640 $930,000
Q2 2024 Aug 09, 2024	SELL	$18.84 - $24.94 $19,782 - $26,187	-1,050 Reduced 3.27%	31,090 $676,000
Q4 2023 Jan 22, 2024	BUY	$12.19 - $22.43 $36,326 - $66,841	2,980 Added 10.22%	32,140 $694,000
Q3 2023 Nov 02, 2023	SELL	$13.28 - $20.3 $18,924 - $28,927	-1,425 Reduced 4.66%	29,160 $493,000
Q2 2023 Jul 21, 2023	SELL	$11.66 - $26.0 $6,121 - $13,650	-525 Reduced 1.69%	30,585 $420,000
Q3 2022 Oct 24, 2022	SELL	$22.51 - $34.32 $46,370 - $70,699	-2,060 Reduced 6.21%	31,110 $811,000
Q4 2021 Feb 10, 2022	BUY	$39.06 - $67.58 $781 - $1,351	20 Added 0.06%	33,170 $1.42 Million
Q2 2021 Jul 28, 2021	SELL	$50.07 - $76.78 $17,524 - $26,873	-350 Reduced 1.04%	33,150 $2.43 Million
Q1 2021 Apr 28, 2021	SELL	$58.92 - $97.33 $58,920 - $97,330	-1,000 Reduced 2.9%	33,500 $2.29 Million
Q4 2020 Feb 09, 2021	SELL	$43.6 - $73.05 $17,440 - $29,220	-400 Reduced 1.15%	34,500 $2.32 Million
Q3 2020 Oct 28, 2020	BUY	$38.47 - $52.03 $40,393 - $54,631	1,050 Added 3.1%	34,900 $1.8 Million
Q1 2020 Apr 29, 2020	BUY	$23.08 - $35.53 $148,981 - $229,346	6,455 Added 23.56%	33,850 $1.01 Million
Q4 2019 Feb 03, 2020	SELL	$15.74 - $35.04 $8,263 - $18,396	-525 Reduced 1.88%	27,395 $942,000
Q3 2019 Oct 23, 2019	BUY	$18.09 - $27.92 $505,072 - $779,526	27,920 New	27,920 $505,000

Others Institutions Holding CSTL

# of Institutions

201

Shares Held

24.5M

Call Options Held

303K

Put Options Held

30.3K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $724M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Capital Management Inc with notifications on news.

Account

Perkins Capital Management Inc Castle Biosciences Inc Transaction History